AAVivo, Inc. to Present at Society for Immunotherapy of Cancer 2025
PR Newswire —
HOUSTON, Nov. 3, 2025 /PRNewswire/ -- AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced a presentation at the Society for Immunotherapy of Cancer 2025, which is being held...